Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-22-058355
Filing Date
2022-09-23
Accepted
2022-09-23 15:33:46
Documents
127
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2022_inmedpharma.htm   iXBRL 10-K 2017367
2 SUBSIDIARIES OF THE COMPANY f10k2022ex21-1_inmedpharma.htm EX-21.1 2225
3 CONSENT OF KPMG LLP f10k2022ex23-1_inmedpharma.htm EX-23.1 2375
4 CERTIFICATION f10k2022ex31-1_inmedpharma.htm EX-31.1 10143
5 CERTIFICATION f10k2022ex31-2_inmedpharma.htm EX-31.2 9931
6 CERTIFICATION f10k2022ex32-1_inmedpharma.htm EX-32.1 3001
7 CERTIFICATION f10k2022ex32-2_inmedpharma.htm EX-32.2 2968
13 GRAPHIC image_001.jpg GRAPHIC 84063
14 GRAPHIC image_002.jpg GRAPHIC 55811
15 GRAPHIC image_003.jpg GRAPHIC 68090
16 GRAPHIC image_004.jpg GRAPHIC 9338
17 GRAPHIC image_005.jpg GRAPHIC 104925
18 GRAPHIC image_006.jpg GRAPHIC 60605
19 GRAPHIC image_007.jpg GRAPHIC 80334
20 GRAPHIC image_008.jpg GRAPHIC 97986
21 GRAPHIC image_009.jpg GRAPHIC 27990
22 GRAPHIC image_010.jpg GRAPHIC 9449
23 GRAPHIC image_011.jpg GRAPHIC 19841
24 GRAPHIC image_012.jpg GRAPHIC 12304
25 GRAPHIC image_013.jpg GRAPHIC 12453
26 GRAPHIC image_014.jpg GRAPHIC 9660
27 GRAPHIC image_015.jpg GRAPHIC 31361
28 GRAPHIC image_016.jpg GRAPHIC 8060
29 GRAPHIC image_017.jpg GRAPHIC 13952
30 GRAPHIC image_018.jpg GRAPHIC 6496
31 GRAPHIC image_019.jpg GRAPHIC 5938
32 GRAPHIC image_020.jpg GRAPHIC 8777
33 GRAPHIC image_021.jpg GRAPHIC 5462
34 GRAPHIC image_022.jpg GRAPHIC 12788
35 GRAPHIC image_023.jpg GRAPHIC 10535
36 GRAPHIC image_024.jpg GRAPHIC 4394
37 GRAPHIC image_025.jpg GRAPHIC 5986
38 GRAPHIC image_026.jpg GRAPHIC 6820
39 GRAPHIC image_027.jpg GRAPHIC 5556
40 GRAPHIC image_028.jpg GRAPHIC 6169
41 GRAPHIC image_029.jpg GRAPHIC 5382
42 GRAPHIC image_030.jpg GRAPHIC 5343
43 GRAPHIC image_031.jpg GRAPHIC 4176
44 GRAPHIC image_032.jpg GRAPHIC 4176
  Complete submission text file 0001213900-22-058355.txt   9870495

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE inm-20220630.xsd EX-101.SCH 90093
9 XBRL CALCULATION FILE inm-20220630_cal.xml EX-101.CAL 35289
10 XBRL DEFINITION FILE inm-20220630_def.xml EX-101.DEF 308250
11 XBRL LABEL FILE inm-20220630_lab.xml EX-101.LAB 657405
12 XBRL PRESENTATION FILE inm-20220630_pre.xml EX-101.PRE 326394
121 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022_inmedpharma_htm.xml XML 909530
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-39685 | Film No.: 221262179
SIC: 2834 Pharmaceutical Preparations